64 Innovative Arboviruses Diagnostic Kit Developed
The Paraná Institute of Molecular Biology (IBMP) has partnered with LGC, Biosearch Technologies to develop a new molecular test for ZDC (zika, dengue and chikungunya).
The innovative kit, which has recently been registered with the National Health Surveillance Agency (Anvisa), can screen for differentiation in the same reaction on the type of dengue (1, 2, 3 or 4).
Mark Dearden, VP of Strategy and Marketing at LGC, Biosearch Technologies, said, “We are delighted that IBMP partnered with LGC Biosearch Technologies for the supply of reliable, high quality custom GMP oligonucleotides and molecular products in Brazil. LGC’s mission is ‘Science for a safer world’ so, clearly, innovative molecular solutions such as this provide a real breakthrough in diagnostic capacity for diseases such as dengue, zika and chikungunya. In addition, several other molecular tests – for malaria, trachoma, yellow fever and leprosy - are also in development and we look forward to combining our expertise to bring further innovation to the diagnostic market.”
Pedro Barbosa, CEO, IBMP, said, “In the constant pursuit of quality and products excellence, IBMP partnered with LGC Biosearch to provide reliable and cost-effective molecular products to the population. This kit is surely the first of many new solutions that we will continue to deliver to society. We exist to deliver healthcare solutions and contribute to increasing access to quality health services and products. Whether in production and development, we have improved our contribution to SUS and the health of the country. IBMP developed and marketed the only registered the molecular discriminatory Zika, Denv1, Denv2, Denv3, Denv4 and Chikungunya test. The product is be the best alternative for both treatment management and surveillance, due to the similar clinical manifestations on patients and the notification need of each arbovírus, respectively.”
51241pr@reply-direct.com Ultra-Pure Porous Plastics for Healthcare Applications
A new state-of-the-art automated manufacturing system is enabling Porvair Sciences to produce ultra-pure porous plastics that are fully compliant with FDA, USP Class VI and European Pharmacopoeia statutory regulations as well as being free from heavy metals.
Kevin Doolan, General Manager of Porvair Sciences said: “Over the last 18 months we have invested significantly in specifying, testing and implementing our enhanced porous plastic manufacturing system. The result is an advanced production platform, with live online measurement capabilities, that can rapidly produce highly consistent and tightly toleranced porous plastics. Moreover, as no release agent is required during the manufacturing process, the resultant porous plastic materials produced have a level of purity that will be readily compatible with even the most challenging healthcare applications.”
He added: “Early feedback from OEM customers receiving Vyon® porous plastic components manufactured using the automated system has been
offers excellent inherent properties for medical and healthcare products. It’s venting capability allows closed environments to breathe whilst maintaining optimal bacterial resistance is a highly desirable and key property in a wide range of medical and pharmaceutical applications.
excellent in terms of ultra-pure product quality, consistency and the competitive pricing we can offer.” Vyon®
Proprietary to Porvair Sciences, Vyon®
enhanced to achieve specific chemical and biochemical separations. Vyon® with aqueous solutions to the Vyon®
available in a range of shapes and sizes to suit your needs. More information online:
ilmt.co/PL/V1o3
is a highly versatile porous plastic which can be modified give hydrophilic or hydrophobic properties, or composite material, an effective shut-off valve is produced and unwanted fluid transmission is prevented. These and other desirable properties have made Vyon®
can also be combined with other materials to create a composite products. For example, by adding a material that swells on contact the
material of choice of porous plastic for medical device / healthcare companies looking to produce drug filters, vents for catheters and medical fluid collection vessels with a competitive advantage. Vyon® is
51145pr@reply-direct.com
Efficient Isolation of Circulating Cell Free DNA
Amsbio has expanded its range of cfPure™ Cell Free DNA Purification Kits for rapid and efficient isolation of circulating cell free DNA (cfDNA). A new cfPure™Max kit is now available for use on samples of 5mLs volume or greater. Amsbio cfPure®
The cfPure® screening. Using proprietary silica-coated magnetic bead technology, cfPure® cell free DNA during isolation - a key success factor for successful analysis of cfDNA. Designed for scalability, cfPure® In addition to being easy to perform, scalable and easy to automate, cfPure®
protocol is rapid and easy, allowing users to process several samples in an hour or less and making it ideal for biomarker kits are able to efficiently recover low molecular weight kits enable you
to use just the number of beads and amount of reagent that you need for your cfDNA extraction. This also means that the number of extractions per kit is dependent on the amount of sample you wish to purify DNA from.
kits allow you to use less magnetic bead solution if you are
purifying small amounts of plasma - saving you money. Since cfDNA is typically found at very low concentrations and in a fragmented state, very efficient DNA capture, as provided by Amsbio’s cfPure™ Cell Free DNA Purification Kits, is vital to provide sensitive and reliable results.
51239pr@reply-direct.com kits use silica-coated paramagnetic particles to purify cell free DNA from less than 1 mL to greater than 10 mL of serum
or plasma. The buffers were developed to ensure efficient recovery of 100 bp – 500 bp DNA fragments in order to maximise recovery of cell free DNA. The recovered DNA is suitable for a wide range of down-stream applications, such as bisulfite sequencing, NGS, and qPCR.
New System Enables Sample Tracking by ID
Safe and distinct sample ID is key for successful results in the lab. The new Eppendorf SafeCode system enables a safe sample vial tracking from the bench to long term storage in the ULT freezer.
SafeCode is based on a multi-level coding of the CryoStorage Vials for sample storage. The coding can be read by the Eppendorf RackScan instrument or any handheld datamatrix scanner.
Enforced by documentation files related to the specific CryoStorage Vial, the sample ID can automatically be transferred into the suitable Eppendorf software for sample location documentation as well as for process documentation.
Eppendorf CryoStorage Vials are available in different volume classes. The pre-racked and pre-capped vials are offered in different purity levels.
The SafeCode system is enhanced by the CryoCube® F740 ULT freezers, VisioNize® freezer notification/ monitoring applications as well as the eLABJournal software as further new building blocks for a smart storage solution of valuable samples. More information online:
ilmt.co/PL/3g2w
51301pr@reply-direct.com
INTERNATIONAL LABMATE - FEBRUARY 2020
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
